Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E WICK

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
American Journal of Optometry and Physiological Optics|November 1, 1979
Management of the aphakic patientR E Wick
Antimicrobial Agents and Chemotherapy|March 1, 1972
Biological properties of three 3-heterocyclic-thiomethyl cephalosporin antibioticsW E Wick, D A Preston
Applied Microbiology|March 1, 1971
Cephaloglycin and its biologically active metabolite desacetylcephaloglycinW E Wick, W E Wright, H V Kuder
The American Journal of Physiology|September 1, 1996
Modeling and simulation of illumination effects for evaluation of microvessels of the conjunctivaC E Wick, M H Loew, J Kurantsin-Mills
Antimicrobial Agents and Chemotherapy|October 1, 1973
Compound 64716, a new synthetic antibacterial agentW E Wick, D A Preston, W A White, et al.
Journal of the American Veterinary Medical Association|June 16, 2011
Comparison of the effect of single-site and multiple-site disk fenestration on the rate of recurrence of thoracolumbar intervertebral disk herniation in dogsBrigitte A Brisson, David L Holmberg, Joane Parent, et al.
American Journal of Physiology. Heart and Circulatory Physiology|October 4, 2005
Interactions of plasma osmolality with arterial and central venous pressures in control of sympathetic activity and heart rate in humansN Charkoudian, J H Eisenach, M J Joyner, et al.
Antimicrobial Agents and Chemotherapy|September 1, 1973
New synthetic antibacterial compound, 1-(2-hydroxyethyl)-3-nitro-4-pyrazole carboxamideW E Wick, D A Preston, N H Terando, et al.
Pharmacopsychiatry|May 1, 1990
Selectivity for omega-receptor subtypes as a strategy for the development of anxiolytic drugsS Z Langer, S Arbilla, S Tan, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|October 8, 2005
Delayed threshold for active cutaneous vasodilation in patients with Type 2 diabetes mellitusDiane E Wick, Shelly K Roberts, Ananda Basu, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
American Journal of Optometry and Physiological Optics|November 1, 1979
Management of the aphakic patientR E Wick
Antimicrobial Agents and Chemotherapy|March 1, 1972
Biological properties of three 3-heterocyclic-thiomethyl cephalosporin antibioticsW E Wick, D A Preston
Applied Microbiology|March 1, 1971
Cephaloglycin and its biologically active metabolite desacetylcephaloglycinW E Wick, W E Wright, H V Kuder
The American Journal of Physiology|September 1, 1996
Modeling and simulation of illumination effects for evaluation of microvessels of the conjunctivaC E Wick, M H Loew, J Kurantsin-Mills
Antimicrobial Agents and Chemotherapy|October 1, 1973
Compound 64716, a new synthetic antibacterial agentW E Wick, D A Preston, W A White, et al.
Journal of the American Veterinary Medical Association|June 16, 2011
Comparison of the effect of single-site and multiple-site disk fenestration on the rate of recurrence of thoracolumbar intervertebral disk herniation in dogsBrigitte A Brisson, David L Holmberg, Joane Parent, et al.
American Journal of Physiology. Heart and Circulatory Physiology|October 4, 2005
Interactions of plasma osmolality with arterial and central venous pressures in control of sympathetic activity and heart rate in humansN Charkoudian, J H Eisenach, M J Joyner, et al.
Antimicrobial Agents and Chemotherapy|September 1, 1973
New synthetic antibacterial compound, 1-(2-hydroxyethyl)-3-nitro-4-pyrazole carboxamideW E Wick, D A Preston, N H Terando, et al.
Pharmacopsychiatry|May 1, 1990
Selectivity for omega-receptor subtypes as a strategy for the development of anxiolytic drugsS Z Langer, S Arbilla, S Tan, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|October 8, 2005
Delayed threshold for active cutaneous vasodilation in patients with Type 2 diabetes mellitusDiane E Wick, Shelly K Roberts, Ananda Basu, et al.
Pageof 2